Evidence map›Paper›PMID 33625469›Full record

ArticleThe Journal of cell biology2021

ZNF416 is a pivotal transcriptional regulator of fibroblast mechanoactivation.

Dakota L Jones, Jeffrey A Meridew, Patrick A Link, Merrick T Ducharme, Katherine L Lydon, Kyoung M Choi, Nunzia Caporarello, Qi Tan, Ana Maria Diaz Espinosa, Yuning Xiong and 7 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. RUNX1 is a mediator of fibrotic activation and epigenetic memory in lung fibroblasts.American journal of respiratory cell and molecular biology · 2026
    Article
  4. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  5. Article
  6. Loss of lung mesenchymal identities in culture and a screening approach to identify restorative cues.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Adiponectin suppresses stiffness-dependent, profibrotic activation of lung fibroblasts.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  16. Article
  17. Transcription factors in fibroblast plasticity and CAF heterogeneity.Journal of experimental & clinical cancer research : CR · 2023
    Review
  18. Article
  19. Mechanoepigenetic regulation of extracellular matrix homeostasis via Yap and Taz.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Dakota L JonesDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Jeffrey A MeridewDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Patrick A LinkDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Merrick T DucharmeDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Katherine L LydonDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Kyoung M ChoiDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Nunzia CaporarelloDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Qi TanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Ana Maria Diaz EspinosaDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Yuning XiongDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.
Jeong-Heon LeeDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.
Zhenqing YeDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Huihuang YanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Tamas OrdogDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Giovanni LigrestiDepartment of Medicine, Boston University, Boston, MA.
Xaralabos VarelasDepartment of Biochemistry, Boston University, Boston, MA.
Daniel J TschumperlinDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Mayo Clinic · USBoston University · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Nicholas F. LaRusso · 2009 to 2026
$22.2M
Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
Interstitial Cells of Cajal in Diabetic GastropathyR01DK058185 · NIDDK · UNIVERSITY OF NEVADA RENO · PI ORDOG, TAMAS · 2002 to 2020
$5.2M
Defining epithelial polarity cues that direct cell fateR01HL124392 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VARELAS, XARALABOS · 2014 to 2024
$4.5M
Interdisciplinary Training in Lung Physiology and Biomedical EngineeringT32HL105355 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2012 to 2021
$3.9M
Epigenetic regulation of pulmonary fibrosisR01HL142596 · NHLBI · MAYO CLINIC ROCHESTER · PI Giovanni Ligresti · 2018 to 2026
$2.9M
Targeting CEBPA To Restore Epithelial-Mesenchymal Homeostasis In Lung FibrosisR01HL153026 · NHLBI · UNIVERSITY OF MINNESOTA · PI TAN, QI · 2020 to 2024
$2.3M
Targeting matrix stiffness in lung and liver fibrosisR01HL133320 · NHLBI · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H., TSCHUMPERLIN, DANIEL J. · 2016 to 2019
$2.2M
NCI NIH HHS P30 CA015083NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R01 HL124392NHLBI NIH HHS R01 HL133320NHLBI NIH HHS R01 HL142596NHLBI NIH HHS R01 HL153026NHLBI NIH HHS T32 HL105355NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK058185
6 · The paper itself

Abstract

Matrix stiffness is a central regulator of fibroblast function. However, the transcriptional mechanisms linking matrix stiffness to changes in fibroblast phenotype are incompletely understood. Here, we evaluated the effect of matrix stiffness on genome-wide chromatin accessibility in freshly isolated lung fibroblasts using ATAC-seq. We found higher matrix stiffness profoundly increased global chromatin accessibility relative to lower matrix stiffness, and these alterations were in close genomic proximity to known profibrotic gene programs. Motif analysis of these regulated genomic loci identified ZNF416 as a putative mediator of fibroblast stiffness responses. Genome occupancy analysis using ChIP-seq confirmed that ZNF416 occupies a broad range of genes implicated in fibroblast activation and tissue fibrosis, with relatively little overlap in genomic occupancy with other mechanoresponsive and profibrotic transcriptional regulators. Using loss- and gain-of-function studies, we demonstrated that ZNF416 plays a critical role in fibroblast proliferation, extracellular matrix synthesis, and contractile function. Together, these observations identify ZNF416 as novel mechano-activated transcriptional regulator of fibroblast biology.

Indexed as

AnimalsCell ProliferationCells, CulturedChromatinExtracellular MatrixFibroblastsFibrosisGene Expression RegulationGenomeLungMiceMice, TransgenicPhenotypeTranscription, GeneticChromatin

Identifiers

PMID33625469
PMCPMC7918622
OpenAlexW3129814643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.